ELIZABETH BROWN: Open Payments
NPI 1437496411 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$772 in 48 payments from 13 companies in 2025. Trend: 2023 $1,094 · 2024 $1,583 · 2025 $772
Food & beverage: $772
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $198 |
| PFIZER INC. | 11 | $151 |
| Otsuka America Pharmaceutical, Inc. | 3 | $76 |
| Lilly USA, LLC | 4 | $58 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $47 |
| Vanda Pharmaceuticals Inc. | 2 | $44 |
| Novo Nordisk Inc | 2 | $42 |
| Astellas Pharma US Inc | 1 | $30 |
| Lundbeck LLC | 1 | $25 |
Products named: VRAYLAR, NURTEC ODT, REXULTI, MOUNJARO, VOQUEZNA, JARDIANCE, FANAPT, Ozempic.
Industry payments across IN — which companies pay providers there.
